Amphastar Pharmaceuticals Inc
F:29A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amphastar Pharmaceuticals Inc
F:29A
|
US |
|
Olimpo Real Estate SOCIMI SA
MAD:YORE
|
ES |
|
DeNA Co Ltd
F:D2N
|
JP |
|
NORDWEST Handel AG
F:NWX
|
DE |
|
F
|
Faes Farma SA
MAD:FAE
|
ES |
|
Harvard Apparatus Regenerative Technology Inc
OTC:HRGN
|
US |
|
HarborOne Bancorp Inc
NASDAQ:HONE
|
US |
|
V
|
Vintcom Technology PCL
SET:VCOM
|
TH |
|
P
|
Pruksa Holding PCL
SET:PSH
|
TH |
|
E
|
EchoStar Corp
SWB:E20
|
US |
|
Transurban Group
ASX:TCL
|
AU |
|
Nisshin Seifun Group Inc
TSE:2002
|
JP |
|
Airtel Africa PLC
OTC:AARTY
|
UK |
|
A
|
Apple Inc
F:APC
|
US |
|
F
|
FACB Industries Incorporated Bhd
KLSE:FACBIND
|
MY |
|
Adani Enterprises Ltd
NSE:ADANIENT
|
IN |
|
B&M European Value Retail SA
F:BMN
|
LU |
|
S
|
SEB SA
F:GRB
|
FR |
Wall St Price Targets
29A Price Targets Summary
Amphastar Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for 29A is 21.89 EUR with a low forecast of 19.27 EUR and a high forecast of 30.04 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 29A's stock price target?
Price Target
21.89
EUR
According to Wall Street analysts, the average 1-year price target for 29A is 21.89 EUR with a low forecast of 19.27 EUR and a high forecast of 30.04 EUR.
What is the Revenue forecast for Amphastar Pharmaceuticals Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 6 years is 3%.
What is the Gross Profit forecast for Amphastar Pharmaceuticals Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Amphastar Pharmaceuticals Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 8%.
What is the Pre-Tax Income forecast for Amphastar Pharmaceuticals Inc?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Amphastar Pharmaceuticals Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 6 years is 4%.
